BiotechTube
Sawai Pharmaceutical

Sawai Pharmaceutical

Osaka, Japan· Est.

Japanese generic pharmaceutical company specializing in value-added cardiovascular and metabolic small molecule drugs to improve patient access and affordability.

global.sawai.co.jp
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

AI Company Overview

Japanese generic pharmaceutical company specializing in value-added cardiovascular and metabolic small molecule drugs to improve patient access and affordability.

CardiovascularMetabolic

Technology Platform

Value-added generic drug development focusing on dosage form modifications, tablet size variations, and administration method improvements to enhance patient adherence and convenience.

Opportunities

Growth opportunities include expanding international presence beyond Japan, leveraging Japan's aging population driving demand for cardiovascular/metabolic drugs, and increasing generic penetration rates through government healthcare cost-containment policies.

Risk Factors

Key risks include intense price competition in generic markets, regulatory challenges for international expansion, potential quality control issues in manufacturing, and dependence on Japanese healthcare policies favoring generic substitution.

Competitive Landscape

Competes with domestic Japanese generic manufacturers like Towa Pharmaceutical and multinational generic companies including Teva and Sandoz; differentiates through value-added formulation improvements and strong domestic manufacturing capabilities.

More companies in Japan →